<DOC>
	<DOCNO>NCT02377245</DOCNO>
	<brief_summary>The investigator create cohort patient juvenile inflammatory rheumatism purpose follow prospectively , investigate tolerance efficacy immunosuppresive biological agent .</brief_summary>
	<brief_title>Juvenile Inflammatory Rheumatism ( JIR ) Cohorte</brief_title>
	<detailed_description>The JIR-cohort fill authorized investigator consultation . Each patient much follow least year . Different data request JIR-cohort : diagnosis , treatment , adverse event outcome .</detailed_description>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<criteria>Patients juvenile inflammatory disease Age onset 18 year old Consent accord national code ethic current law Nonconsent patient and/or legal representative</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Juvenile</keyword>
	<keyword>Inflammatory</keyword>
	<keyword>Rheumatism</keyword>
	<keyword>Pediatric-Onset inflammatory disease</keyword>
</DOC>